The agreement extends Idaho Technology’s ongoing program to license its broad and valuable intellectual property portfolio in cooperation with Roche Diagnostics. Several of the Idaho Technology’s products, including the LightCycler Instrument, have been sublicensed to Roche Diagnostics.

Idaho and DuPont said that the agreement, effective from June 18, 2010, follows a series of intellectual property licensing agreements with a number of other biotechnology companies over the last several years.

Idaho Technology’s SYBR intellectual property has been useful expanding applications in molecular biology with the use of real time PCR products.

Idaho Technology is a privately held biotechnology company which licensed the rapid PCR technology from the University of Utah.

Through funds from the US Department of Health and Human Services and the Department of Defense, Idaho has created many commercial instruments and reagents for use in research and applied fields.

Idaho and DuPont said that the researchers, medical technicians, law enforcement officers and soldiers in the field use the company’s devices to detect or study disease-causing organisms.